MNDA (CT) Peptide

MNDA Antibody: MNDA controls the expression of MCL-1 and BCL02 in chronic lymphocytic leukemia cells. MNDA is also a useful marker in the recognition and differential diagnosis of marginal zone lymphomas. MNDA has a role in regulating programmed cell death in myeloid progenitor cells, and its down-regulation in myelodysplastic syndromes is related to granulocyte-macrophage progenitor cell sensitivity to TRAIL-induced programmed cell death.

4332

P41218.1

P41218.1

Peptides

200 ug/mL

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Blue Ice

Store MNDA (CT) Peptide at -20˚ C, stable for one year.

MNDA (CT) Peptideis used for blocking the activity of theMNDA (CT) Antibody

Myeloid cell nuclear differentiation antigen

Homo sapiens

Bottari et al. Exp Hematol. 2020; 88:68-82

Wang et al. Am. J. Clin. Pathol. 2019; 151 (3) :337-343

Kanellis et al. Lukemia 2019; 23 (10) :1847-1857

Briggs et al. Cancer Res. 2006; 66 (9) : 4645-4651

MNDA

Blocking

Human

730038

Liquid